Genocea Biosciences Inc (GNCA:NASDAQ) Investor Relations Material

Overview

Genocea Biosciences is a biopharmaceutical company specializing in the development of vaccines and immunotherapies to treat infectious diseases. The company employs its proprietary discovery platform, AnTigen Lead Acquisition System, to design innovative vaccines and immunotherapies that act through T cell immune responses.

Annual Reports

Frequently Asked Questions

What is Genocea Biosciences Inc's ticker?

Genocea Biosciences Inc's ticker is GNCA

What exchange is Genocea Biosciences Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Genocea Biosciences Inc's headquarters?

They are based in Cambridge, Massachusetts

How many employees does Genocea Biosciences Inc have?

There are 51-200 employees working at Genocea Biosciences Inc

What is Genocea Biosciences Inc's website?

It is http://www.genocea.com/

What type of sector is Genocea Biosciences Inc?

Genocea Biosciences Inc is in the Healthcare sector

What type of industry is Genocea Biosciences Inc?

Genocea Biosciences Inc is in the Biotechnology industry

Who are Genocea Biosciences Inc's peers and competitors?

The following five companies are Genocea Biosciences Inc's industry peers:

- Ergomed

- NGM Biopharmaceuticals, Inc.

- Atreca, Inc.

- Microbix Biosystems Inc.

- Dyadic International